Ferring Pharmaceuticals has opened its new U.S. Operations Center in Parsippany, NJ. The facility recently completed the integration of staff into the new manufacturing suite and product development labs, which will house 275 employees across management, administration, commercial operations, manufacturing and R&D. Ferring plans to add more staff as the manufacturing facility comes online over the course of the next 18 to 24 months. 

“This is just the start of an exciting journey of growth to come,” said Michel Pettigrew, chief executive officer, Ferring Holding Inc. and president of the executive board and chief operating officer, Ferring Group. “We hope this new operations center stands as a symbol of our philosophy as a company – a place where our commitment to the science and to our patients is front and center; a learning environment where employees are encouraged to take initiative and stretch beyond their designated role; and a cornerstone of the community, dedicated to giving back.” 

“This grand opening serves as a reminder of our commitment to the U.S., NJ and to our long-term view on the science that can make a real difference in the lives of the patients we serve,” said Aaron Graff, president and chief operating officer Ferring Pharmaceuticals. “As I watch our teams start to integrate into the new operations center, I already see the positive impact the space has on our ability to collaborate across functions within the organization and provide a premium workspace for our employees.”